Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first
--------------------------------------------------------------------
Source: CNBC
Published: 2026-07-22 09:48 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Business, China, Financial Markets, Business & Economy
--------------------------------------------------------------------
Snippet:
For years, Chinese companies such as Alibaba and Baidu headed to the U.S. to list their shares, citing its deeper capital markets and higher valuations. Now, one American biotech firm is betting on doing the opposite.
--------------------------------------------------------------------